Cosmax Inc (192820) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cosmax Inc (192820) has a cash flow conversion efficiency ratio of 0.115x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩58.24 Billion ≈ $39.47 Million USD) by net assets (₩506.65 Billion ≈ $343.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Cosmax Inc (192820) defensive interval to measure how many days the company can operate on defensive assets alone.
Cosmax Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Cosmax Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cosmax Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cosmax Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Is Yatirim Menkul Degerler AS
IS:ISMEN
|
0.047x |
|
Celltrion Pharm Inc
KQ:068760
|
0.055x |
|
ATAI Life Sciences NV
XETRA:9VC
|
-0.145x |
|
Radiant Opto-Electronics Corp
TW:6176
|
-0.005x |
|
SkiStar AB (publ)
ST:SKIS-B
|
0.072x |
|
Triumph Financial, Inc.
NASDAQ:TFIN
|
0.027x |
|
BioLife Solutions Inc
NASDAQ:BLFS
|
-0.001x |
|
Anadolu Anonim Turk Sigorta Sti
IS:ANSGR
|
0.069x |
Annual Cash Flow Conversion Efficiency for Cosmax Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of Cosmax Inc from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see Cosmax Inc (192820) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩508.81 Billion ≈ $344.81 Million |
₩72.97 Billion ≈ $49.45 Million |
0.143x | -77.74% |
| 2023-12-31 | ₩358.56 Billion ≈ $242.99 Million |
₩231.02 Billion ≈ $156.56 Million |
0.644x | +179.16% |
| 2022-12-31 | ₩444.25 Billion ≈ $301.06 Million |
₩102.53 Billion ≈ $69.48 Million |
0.231x | +7.36% |
| 2021-12-31 | ₩465.38 Billion ≈ $315.38 Million |
₩100.05 Billion ≈ $67.80 Million |
0.215x | +40.98% |
| 2020-12-31 | ₩271.90 Billion ≈ $184.26 Million |
₩41.46 Billion ≈ $28.10 Million |
0.152x | -35.29% |
| 2019-12-31 | ₩316.47 Billion ≈ $214.47 Million |
₩74.57 Billion ≈ $50.53 Million |
0.236x | +204.38% |
| 2018-12-31 | ₩241.85 Billion ≈ $163.90 Million |
₩-54.59 Billion ≈ $-37.00 Million |
-0.226x | -679.16% |
| 2017-12-31 | ₩228.39 Billion ≈ $154.77 Million |
₩-6.62 Billion ≈ $-4.48 Million |
-0.029x | -125.59% |
| 2016-12-31 | ₩207.31 Billion ≈ $140.49 Million |
₩23.47 Billion ≈ $15.90 Million |
0.113x | +268.01% |
| 2015-12-31 | ₩96.52 Billion ≈ $65.41 Million |
₩-6.50 Billion ≈ $-4.41 Million |
-0.067x | -563.91% |
| 2014-12-31 | ₩80.53 Billion ≈ $54.58 Million |
₩1.17 Billion ≈ $792.68K |
0.015x | -- |
About Cosmax Inc
Cosmax, Inc. researches, develops, produces, and manufactures cosmetic and health function food products in Korea and internationally. The company operates through Cosmetic Business segment, Custom Cosmetic, and other Business segments. The company offers skincare products under the Capsule+, IS-LCE, CeraPresso, Emulixir, Foamology, IRPT, and Solar Clear brands; base-make up under the Air Cloud, … Read more